These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 12747758

  • 1. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
    Liu Z, Lee FT, Hanai N, Smyth FE, Burgess AW, Old LJ, Scott AM.
    Cancer Immun; 2002 Oct 07; 2():13. PubMed ID: 12747758
    [Abstract] [Full Text] [Related]

  • 2. Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.
    Scott AM, Liu Z, Murone C, Johns TG, MacGregor D, Smyth FE, Lee FT, Cebon J, Davis ID, Hopkins W, Mountain AJ, Rigopoulos A, Hanai N, Old LJ.
    Cancer Immun; 2005 Feb 22; 5():3. PubMed ID: 15723450
    [Abstract] [Full Text] [Related]

  • 3. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E, Alvarez E, Cantó E, Vidal S, Rodríguez-Sánchez JL, Sierra J, Briones J.
    Exp Hematol; 2008 Jan 22; 36(1):69-77. PubMed ID: 17959301
    [Abstract] [Full Text] [Related]

  • 4. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
    Flieger D, Spengler U, Beier I, Sauerbruch T, Schmidt-Wolf IG.
    Z Gastroenterol; 2000 Aug 22; 38(8):615-22. PubMed ID: 11031784
    [Abstract] [Full Text] [Related]

  • 5. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
    Batova A, Kamps A, Gillies SD, Reisfeld RA, Yu AL.
    Clin Cancer Res; 1999 Dec 22; 5(12):4259-63. PubMed ID: 10632368
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma.
    Munn DH, Cheung NK.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6600-5. PubMed ID: 3499978
    [Abstract] [Full Text] [Related]

  • 7. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W, Nishioka Y, Ozaki S, Jalili A, Verma VK, Hanibuchi M, Abe S, Minakuchi K, Matsumoto T, Sone S.
    Lung Cancer; 2009 Jan 15; 63(1):23-31. PubMed ID: 18524412
    [Abstract] [Full Text] [Related]

  • 8. The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fc gamma receptor expression and antibody-dependent cellular cytotoxicity of hematopoietic progenitor cells during in vitro myeloid maturation.
    Ericson SG, Benoit NE, Mills LE, Fanger MW.
    Exp Hematol; 1994 Mar 15; 22(3):283-9. PubMed ID: 7509291
    [Abstract] [Full Text] [Related]

  • 9. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.
    Cancer Res; 2001 Nov 01; 61(21):7925-33. PubMed ID: 11691814
    [Abstract] [Full Text] [Related]

  • 10. Combinations of the cytokines IL-12, IL-2 and IFN-alpha significantly augment whereas the cytokine IL-4 suppresses the cytokine-induced antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2.
    Flieger D, Spengler U, Beier I, Sauerbruch T, Schmidt-Wolf I.
    Cytokine; 2000 Jun 01; 12(6):756-61. PubMed ID: 10843759
    [Abstract] [Full Text] [Related]

  • 11. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K, Varalakshmi C, Khar A.
    Cytokines Cell Mol Ther; 1997 Mar 01; 3(1):51-8. PubMed ID: 9287244
    [Abstract] [Full Text] [Related]

  • 12. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR, Woodhouse C, Morgan AC, Herberman RB, Cheresh DA, Reisfeld R.
    J Immunol; 1987 May 15; 138(10):3566-72. PubMed ID: 2437198
    [Abstract] [Full Text] [Related]

  • 13. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ, Cameron C, Lazo S, Cochran KJ, Voss SD, Ritz J.
    Nat Immun; 1987 May 15; 15(5):213-26. PubMed ID: 9390270
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
    Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G.
    Cell Immunol; 1994 Jul 15; 156(2):480-92. PubMed ID: 7912999
    [Abstract] [Full Text] [Related]

  • 16. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F.
    Hum Immunol; 2004 Feb 15; 65(2):142-56. PubMed ID: 14969769
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia.
    Caron PC, Lai LT, Scheinberg DA.
    Clin Cancer Res; 1995 Jan 15; 1(1):63-70. PubMed ID: 9815888
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X, Zhang L, Solomon GF, Bonavida B.
    Brain Behav Immun; 2002 Jun 15; 16(3):227-46. PubMed ID: 12009684
    [Abstract] [Full Text] [Related]

  • 19. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L, Adams M, Carter T, Chen R, Muller G, Stirling D, Schafer P, Bartlett JB.
    Clin Cancer Res; 2008 Jul 15; 14(14):4650-7. PubMed ID: 18628480
    [Abstract] [Full Text] [Related]

  • 20. Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).
    Hank JA, Surfus JE, Gan J, Jaeger P, Gillies SD, Reisfeld RA, Sondel PM.
    Clin Cancer Res; 1996 Dec 15; 2(12):1951-9. PubMed ID: 9816154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.